Ultrasound-Assisted Blood-Brain Barrier Opening Monitoring by Photoacoustic and Fluorescence Imaging Using Indocyanine Green.
Authors: Ador T, Fournié M, Rigollet S, Counil C, Stupar V, Barbier EL, Pichon C, Delalande A
The blood-brain barrier (BBB) is a selectively permeable membrane that restricts drug delivery to the central nervous system. Focused ultrasound (FUS) combined with microbubbles (MBs) is a promising technique to transiently open the BBB, enabling therapeutic delivery. However, real-time monitoring of BBB permeability changes remains challenging. This study investigated the use of indocyanine green (ICG) as a bi-modal contrast agent for photoacoustic and fluorescence imaging to assess BBB opening and closure dynamics. BALB/c mice underwent FUS-mediated BBB opening with different doses of MBs and ICG administration. Photoacoustic and fluorescence imaging were performed at various time points post-FUS to evaluate ICG extravasation dynamics. Magnetic resonance imaging (MRI) with gadolinium contrast was used as the gold standard for BBB permeability assessment. The effect of MB dose and injection timing on BBB closure kinetics was analyzed. Photoacoustic imaging provided reliable BBB monitoring within the first hour post-FUS, whereas fluorescence imaging was more effective at detecting ICG extravasation at 24 h. A strong correlation was observed between fluorescence intensity and MRI-based contrast enhancement, confirming BBB opening dynamics. BBB closure followed an exponential decay model, with a half-closure time of approximately 81 min. The degree of BBB opening was proportional to the MB dose administered. ICG-based photoacoustic and fluorescence imaging provide a non-invasive and cost-effective alternative to MRI for monitoring FUS-induced BBB opening. These techniques offer complementary temporal windows for assessment, improving the precision of BBB permeability evaluation in preclinical and potentially clinical applications.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To evaluate monitoring of ultrasound-assisted blood–brain barrier opening using photoacoustic and fluorescence imaging with indocyanine green.
Disease model
Healthy
Cargo name and characteristics
Indocyanine Green (ICG) — a small-molecule near‑infrared (NIR) fluorescent dye/imaging contrast agent (FDA-approved), a cyanine dye that binds plasma proteins and is used for photoacoustic and fluorescence imaging.
Outcomes and Safety
Summary of Outcomes
Focused ultrasound–assisted blood–brain barrier opening enabled indocyanine green (ICG) to penetrate the brain and this delivery was successfully monitored by photoacoustic and fluorescence imaging; no specific focused ultrasound parameter values were provided in the text supplied.
Safety-related matter
The provided text contains only the article title and includes no mention of safety or adverse effects; therefore no safety information or adverse event findings are available from this excerpt.
Brain Region
Ultrasound Parameters
Focal Characteristics
Focal depth: None; Focal length: None; Aperture size: None
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search